Clinical Trial Update: Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial evaluating the safety and efficacy of linaclotide in children aged 6 to 17 with functional constipation or irritable bowel syndrome wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: AbbVie | Conditions: Functional Constipation, Irritable Bowel Syndrome With Constipation | Phase 3 | Status: COMPLETED | Results posted: 2024-11-26